Calamos Advisors’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.79M Sell
106,017
-1,074
-1% -$70.6K 0.02% 508
2026
Q1
$7.62M Hold
107,091
0.03% 467
2025
Q4
$8.78M Sell
107,091
-2,491
-2% -$194K 0.03% 426
2025
Q3
$8.23M Buy
109,582
+70
+0.1% +$5.22K 0.03% 450
2025
Q2
$8.11M Buy
109,512
+738
+0.7% +$51.4K 0.03% 463
2025
Q1
$8.78M Buy
108,774
+711
+0.7% +$61.1K 0.04% 422
2024
Q4
$8.45M Hold
108,063
0.04% 429
2024
Q3
$10.1M Sell
108,063
-1,548
-1% -$130K 0.04% 404
2024
Q2
$8.54M Sell
109,611
-2,360
-2% -$192K 0.04% 442
2024
Q1
$10.2M Sell
111,971
-1,685
-1% -$140K 0.05% 392
2023
Q4
$8.79M Sell
113,656
-897
-0.8% -$62.8K 0.04% 423
2023
Q3
$7.79M Hold
114,553
0.04% 457
2023
Q2
$9.31M Hold
114,553
0.05% 444
2023
Q1
$9.4M Buy
+114,553
New +$8.18M 0.05% 462

Other funds holding GEHC

Calamos Advisors's GEHC Position: Q2 2026 in Review

Calamos Advisors reduced its GE HealthCare (GEHC) stake by 1% in Q2 2026, selling an estimated $70.6K and leaving 106,017 shares worth $6.79M. The position accounts for 0.02% of the portfolio, ranked #508.

Calamos Advisors first reported a position in GEHC in Q1 2023 and has held it in 14 quarters since. The position peaked at $10.2M in Q1 2024. 1,226 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Calamos Advisors held 106,017 shares of GE HealthCare worth $6.79M as of Q2 2026.
  • Calamos Advisors sold 1,074 GE HealthCare shares in Q2 2026, an estimated $70.6K.
  • GE HealthCare made up 0.02% of Calamos Advisors's portfolio in Q2 2026, its #508 holding.
  • Calamos Advisors first reported a position in GE HealthCare in Q1 2023 and has held it in 14 quarters since.
  • Calamos Advisors's GE HealthCare position peaked at $10.2M in Q1 2024.
  • 1,226 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Calamos Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.